Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition

Advisory Committee on Immunization Practices

FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION

ACIP Recommendations: Topics of interest

View All Childhood HepB Birth Dose Pregnancy
Adolescents Combination Vaccines HIV Registries
Adoption Dialysis Long-Term Care Schedules
Adults General Recommendations Men + Men Travel
Biopreparedness Healthcare Personnel Postexposure Prophylaxis
 

Recommendations - Adolescents

Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, August 29, 2014; 63(RR-5):1-30
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, January 28, 2011; 60(03):72-76
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 28, 2010; 59(20):626-629
HTML  |  PDF
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
Source: MMWR, May 28, 2010; 59(20):630-632
HTML  |  PDF
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
HTML  |  PDF
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795
HTML  |  PDF
Quadrivalent Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24
 
HTML  |  PDF
Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines Among Adolescents
Please note: If you are using the HTML version of this document, be sure to access all the HTML links to get the complete content of the document, which includes important appendices.
Source: MMWR, March 24, 2006, Vol. 55(RR03):1-49
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  HTML pt.5 |  HTML pt.6  |  HTML pt.7  |  PDF (entire issue)
#

Recommendations - Adoption

Back to top
Persons Vaccinated Outside the United States, Including Internationally Adopted Children
Source: See pp. 33-34, Table 12, General Recommendations on Immunization MMWR, December 1, 2006; 51(RR-2):1-48
HTML  |  PDF
#

Recommendations - Adults

Back to top
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, September 19, 2014; 63(37):822-825
HTML  |  PDF
Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, August 29, 2014; 63(RR-5):1-30
HTML  |  PDF
Update on Recommendations for Use of Herpes Zoster Vaccine
Source: MMWR, August 22, 2014; 63(33):729-731
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
Source: MMWR, June 1, 2012; 61(21):394-5
HTML  |  PDF
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8
HTML  |  PDF
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source:: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6
HTML  |  PDF
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010
Source: MMWR, April 30, 2010; 59(16):485-486
HTML  |  PDF
Recommended Adult Immunization Schedule--United States, 2010
Source: MMWR, January 15, 2010; 59(01:1-4)
HTML  |  PDF
Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 6, 2008; 57(05):1-30
HTML  |  PDF
Quadrivalent Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24
HTML  |  PDF
Preventing Tetanus, Diphtheria, and Pertussis among Adults: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 15, 2006;55(RR-17):1-33
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part II: Immunization of Adults
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 8, 2006;55(RR-16):1-25R
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB)
HTML  |  PDF
Prevention of Pneumococcal Disease
Source: MMWR April 04, 1997 / Vol. 46 / No. RR-08
HTML  |  PDF
Update on Adult Immunization
Source: MMWR November 15, 1991 / Vol. 40 / No. RR-120
HTML  |  PDF
#

Recommendations - Biopreparedness

Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
Source: MMWR, July 23, 2010; 59(rr06):1-36
HTML  |  PDF
Recommendations for Using Smallpox Vaccine in a Pre-Event Vaccination Program
Source: MMWR, Recommendations and Reports, April 4, 2003, Vol. 52(RR-7)
HTML  |  PDF
Use of Anthrax Vaccine in Response to Terrorism
Source: MMWR, November 15, 2002, Vol. 51(45):1024-1026
HTML  |  PDF
Vaccinia (Smallpox) Vaccine
Source: MMWR June 22, 2001 / Vol. 50 / No. RR-10
HTML  |  PDF
Use of Anthrax Vaccine in the United States
Source: MMWR December 15, 2000 / Vol. 49 / No. RR-15
HTML  |  PDF
Prevention of Plague
Source: MMWR December 13, 1996 / Vol. 45 / No. RR-14
HTML  |  PDF
#

Recommendations - Childhood

Back to top
Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, August 29, 2014; 63(RR-5):1-30
HTML  |  PDF
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
Source: MMWR, June 20, 2014; 63(24):527-530
HTML  |  PDF
Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports
Source: MMWR, February 28, 2014; 63(RR01):1-14
HTML  |  PDF
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
Source: MMWR, September 20, 2013; 62(RR–7):1-48
HTML  |  PDF
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 28, 2013; 62(25):521-524
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, March 22, 2013; 62(RR02):1-22
HTML  |  PDF
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
Source: MMWR, January 25, 2013; 62(3):52-4
HTML  |  PDF
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, October 14, 2011; 60(40):1391-2
HTML  |  PDF
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, August 5, 2011; 60(30):1018-1019
HTML  |  PDF
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
Source: MMWR, December 10, 2010; 59(RR11):1-18
HTML  |  PDF
Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Regarding Use of CSL Seasonal Influenza Vaccine (Afluria) in the United States During 2010-11
Source: MMWR, August 13, 2010; 59(31):989-92
HTML  |  PDF
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16
HTML  |  PDF
Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):258-261
HTML  |  PDF
Licensure of a Haemophilus influenzae Type b (Hib) Vaccine (Hiberix) and Updated Recommendations for Use of Hib Vaccine
Source: MMWR September 18, 2009; 58(36):1008-1009
HTML  |  PDF
Prevention of Rotavirus Gastroenteritis Among Infants and Children: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, February 6, 2009, Vol. 58 (RR-2)
HTML  |  PDF
Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344
HTML  |  PDF
Notice to Readers: Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2--10 Years at Increased Risk for Invasive Meningococcal Disease
Source: MMWR, December 7, 2007; 56(48):1265-1266
HTML  |  PDF
Expansion of Use of Live Attenuated Influenza Vaccine (FluMist) to Children Aged 2-4 Years and Other FluMist Changes for the 2007--08 Influenza Season
Source: MMWR, November 23, 2007; 56(46):1217-1219
HTML  |  PDF
Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11--18 Years with Meningococcal Conjugate Vaccine
Source: MMWR, August 10, 2007; 56(31):794-795
HTML  |  PDF
Prevention of Varicella
Source: MMWR, June 22, 2007; 56(RR-4):1-40
HTML  |  PDF
Quadrivalent Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24
HTML  |  PDF
Control and Elimination of Mumps
Source: MMWR, June 9, 2006, Vol. 55(22):629-630
HTML  |  PDF
Prevention and Control of Meningococcal Disease
Source: MMWR, May 27, 2005, Vol. 54(RR07):1-21
HTML  |  PDF
Using Live, Attenuated Influenza Vaccine for Prevention and Control of Influenza
Source: MMWR, September 26, 2003, Vol. 52/No. RR-13 (file size 402 KB)
HTML  |  PDF
Use of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine as a Five-Dose Series
Source: MMWR November 17, 2000 / Vol. 49 / No. RR-13
HTML  |  PDF
Preventing Pneumococcal Disease Among Infants and Young Children
Source: MMWR October 6, 2000 / Vol. 49 / No. RR-09
HTML  |  PDF
Prevention and Control of Meningococcal Disease
Source:MMWR June 30, 2000 / Vol. 49 / No. RR-07
HTML  |  PDF
Poliomyelitis Prevention in the United States
Source: MMWR May 19, 2000 / Vol. 49 / No. RR-05
HTML  |  PDF
Use of Haemophilus b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13
HTML  |  PDF
Diphtheria, Tetanus, and Pertussis, Recommendations for Vaccine Use and Other Preventive Measures
Source: MMWR August 8, 1991 / Vol. 40 / No. RR-10
HTML  |  PDF
Haemophilus b Conjugate Vaccines for Prevention of Hib Disease
Source: MMWR January 11, 1991 / Vol. 40 / No. RR-01
HTML  |  PDF
#

Recommendations - Combination Vaccines

Back to top
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 7, 2010; 59(RR--3):1 - 16
HTML  |  PDF
Combination Vaccines for Childhood Immunization
Source: MMWR May 14, 1999 / Vol. 48 / No. RR-05
HTML  |  PDF
Use of Haemophilus b Conjugate Vaccines and a Combined DTP and Hib Vaccine
Source: MMWR September 17, 1993 / Vol. 42 / No. RR-13
HTML  |  PDF
#

Recommendations - Dialysis

Guidelines for Vaccinating Kidney Dialysis Patients and Patients with Chronic Kidney Disease
Source: Centers for Disease Control and Prevention, June 2006
HTML  PDF
Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients
(not an ACIP statement but an important update document)

Source: MMWR, April 27, 2001 / Vol. 50 / No. RR-5
HTML  |  PDF
#

General Recommendations

Back to top
General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
HTML  |  PDF
#

Recommendations - Healthcare Personnel

Back to top
CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management – Recommendations and Reports
Source: MMWR, December 20, 2013; 62(rr10);1-19
(Not an ACIP statement but an important document from CDC.)
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students
(Not an ACIP statement but an important document from CDC.)
Source: MMWR, July 6, 2012; 61(RR03):1-12
HTML  |  PDF
Immunization of Health-Care Personnel: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, November 25, 2011; 60(RR07):1-45
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, October 21, 2011; 60(41):1424-1426
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
 
Use of Influenza A (H1N1) 2009 Monovalent Vaccine
Source: MMWR, August 28, 2009; 58(RR10):1-8
HTML  |  PDF
Influenza Vaccination of Health-Care Personnel
Source: MMWR, February 24, 2006, Vol. 55(RR02):1-16
HTML  |  PDF
Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
(not an ACIP statement but an important update document)
Source: MMWR June 29, 2001 / Vol. 50 / No. RR-11
HTML  |  PDF
#

Recommendations - HepB Birth Dose

A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Part 1: Immunization of Infants, Children and Adolescents.
Source: MMWR, December 23, 2005, Vol. 54(RR-16):1-39
HTML PT.1  |  HTML PT.2  |  HTML PT.3  |  HTML PT.4  |  PDF
Dear Colleague Letter: Universal Infant Hepatitis B Vaccination Should Begin At Birth, January 18, 2006
Authors: Lance Rodewald and John Ward
Source: Centers for Disease Control and Prevention
HTML  |  PDF
#

Recommendations - HIV

Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children: Recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics
(Not an ACIP statement, but an important new recommendation from CDC.)
Source: MMWR, September 4, 2009; 58(RR11):1-166
HTML  |  PDF
CDC Guidelines: Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Setting
(Not an ACIP statement, but an important new recommendation from CDC)
Source: MMWR, September 22, 2006, Vol. 55(RR14):1-17
HTML  |  PDF
Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis
(not an ACIP statement but an important update document)
Source: MMWR June 29, 2001 / Vol. 50 / No. RR-11
HTML  |  PDF
Recommendations for Preventing Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures
(not an ACIP statement but an important document)
Source: MMWR, July 12, 1991 / Vol. 40 / No. RR08
HTML
#

Recommendations - Long-Term Care

Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
Source: MMWR, September 3, 2010; 59(34):1102-6
HTML  |  PDF
Prevention of Pneumococcal Disease
Authors: Lance Rodewald and John Ward
Source: Centers for Disease Control and Prevention
HTML  |  PDF
Notice to Readers: Facilitating Influenza and Pneumococcal Vaccination Through Standing Orders Programs
Author: Centers for Disease Control and Prevention
Source: MMWR, January 31, 2003, Vol. 52(04):68-9
HTML  |  PDF
#

Recommendations - Men Who Have Sex With Men

ACIP Recommendations Update: Prevention of Hepatitis A after Exposure to Hepatitis A Virus and in International Travelers
Source: MMWR, October 19, 2007; 56(41):1080-1084
HTML  |  PDF
ACIP Recommendations: A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part II: Immunization of Adults
 Source: MMWR, December 8, 2006;55(RR-16):1-25
HTML PT.1  |  HTML PT.2  |  HTML PT.3  |  HTML PT.4  |  PDF
Prevention of Hepatitis A Through Active or Passive Immunization
Source: MMWR, May 19, 2006, Vol. 55(RR07):1-23
HTML  |  PDF
Sexually Transmitted Diseases Treatment Guidelines, 2006
Source: MMWR, August 4, 2006, Vol. 55(RR11):1-94
HTML  |  PDF
CDC Dear Colleague Letter on Recommended Sexually Transmitted Diseases (STD) Prevention Services for Men Who Have Sex With Men (MSM)
Source: CDC's Division Viral Hepatitis, Division of Sexually Transmitted Diseases, Division of Immunization Services, and Division of HIV/AIDS Prevention.
HTML  |  PDF
#

Recommendations - Postexposure Prophylaxis

Back to top
Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies
Source: MMWR, March 19, 2010; 59(02):1-9
HTML  |  PDF
Update: Prevention of Hepatitis A after Exposure to Hepatitis A Virus and in International Travelers
Source: MMWR, October 19, 2007; 56(41):1080-1084
HTML  |  PDF
Investigational Product (VariZIG) for Postexposure Prophylaxis of Varicella
Source: MMWR, February 24, 2006, Vol. 55:1-2
HTML  |  PDF
Postexposure Prophylaxis/Pertussis/CDC Treatment Guidelines: Recommended Antimicrobial Agents for the Treatment and Postexposure Prophylaxis of Pertussis
(not an ACIP statement but a recommendation from NIP, CDC)
Source: MMWR, December 9, 2005, Vol. 54(RR14):1-16
HTML  |  PDF
#

Recommendations - Pregnancy

Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, February 22, 2013;62(07):131-5
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
Source: MMWR, June 29, 2012; 61(25):468-70
HTML  |  PDF
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
Source:: MMWR, January 14, 2011; 60(01):13-15
HTML  |  PDF
Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, May 30, 2008; 57 (04):1-47,51
HTML pt 1  | HTML pt 2  | HTML pt 3  | PDF
ACIP: Guidance for Vaccine Recommendations in Pregnant and Breastfeeding Women
Source: Centers for Disease Control and Prevention, April 2008
HTML  PDF
Guidelines for Vaccinating Pregnant Women: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: Centers for Disease Control and Prevention, Updated May 2007
HTML  |  PDF
CDC Guidelines: Evaluation and Management of Suspected Outbreaks, Rubella in Pregnant Women, and Surveillance for Congenital Rubella Syndrome
(not an ACIP statement but an important update document)
Source: MMWR July 13, 2001 / Vol. 50 / No. RR-12
HTML  |  PDF
#

Recommendations - Registries

CDC Guidelines: Development of Community- and State-Based Immunization Registries
(not an ACIP statement but an important document)
Source: MMWR October 5, 2001 / Vol 50 / No. RR-17
HTML  |  PDF
#

Recommendations - Schedules

Advisory Committee on Immunization Practices Recommended Immunization Schedules for Persons Aged 0 Through 18 Years — United States, 2014
Source: MMWR, February 7, 2014; 63(5):108109
HTML  |  PDF
Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2014
Source: MMWR, February 7, 2014; 63(5):110112
HTML  |  PDF
#

Recommendations - Travel

Back to top
Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
Source: MMWR, November 15, 2013; 62(45):898-900
HTML  |  PDF
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, June 14, 2013; 62(RR04):1-34
HTML  |  PDF
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine -- Advisory Committee on Immunization Practices, 2011
Source: MMWR, May 27, 2011; 60(20):661-3
HTML  |  PDF
Update on Japanese Encephalitis Vaccine for Children
Source: MMWR, May 27, 2011; 60(20):664-5
HTML  |  PDF
Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, July 30, 2010; 59(RR07):1-27
HTML  |  PDF
Japanese Encephalitis Vaccines
Source: MMWR, March 12, 2010; 59(01):1-27
HTML  |  PDF
Human Rabies Prevention--United States, 2008: Recommendations of the Advisory Committee on Immunization Practices
Source: MMWR, May 23, 2008; 57(RR03):1-26,28
HTML pt 1 | HTML pt 2 |  PDF
Update: Prevention of Hepatitis A after Exposure to Hepatitis A Virus and in International Travelers
Source: MMWR, October 19, 2007; 56(41):1080-1084
HTML  |  PDF
A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States. Part II: Immunization of Adults
Please note: If you are using the HTML version of this document, be sure to access all four HTML links to get the complete content of the document, which includes 3 important appendices.
Source: MMWR, December 8, 2006;55(RR-16):1-25R
HTML pt.1  |  HTML pt.2  |  HTML pt.3  |  HTML pt.4  |  PDF (entire issue)
Prevention of Hepatitis A Through Active or Passive Immunization
Source: MMWR, May 19, 2006, Vol. 55(RR07):1-23
HTML  |  PDF
Yellow Fever Vaccine
Source: MMWR, November 8, 2002, Vol. 51/RR17
HTML  |  PDF
Typhoid Immunization
Source: MMWR December 9, 1994/ Vol. 43/ No. RR-14
HTML  |  PDF
This page was reviewed on September 19, 2014
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.